1. Home
  2. CPRX vs COMP Comparison

CPRX vs COMP Comparison

Compare CPRX & COMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • COMP
  • Stock Information
  • Founded
  • CPRX 2002
  • COMP 2012
  • Country
  • CPRX United States
  • COMP United States
  • Employees
  • CPRX N/A
  • COMP N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • COMP EDP Services
  • Sector
  • CPRX Health Care
  • COMP Technology
  • Exchange
  • CPRX Nasdaq
  • COMP Nasdaq
  • Market Cap
  • CPRX 2.8B
  • COMP 2.8B
  • IPO Year
  • CPRX 2006
  • COMP 2021
  • Fundamental
  • Price
  • CPRX $20.60
  • COMP $6.32
  • Analyst Decision
  • CPRX Strong Buy
  • COMP Buy
  • Analyst Count
  • CPRX 6
  • COMP 8
  • Target Price
  • CPRX $30.50
  • COMP $5.34
  • AVG Volume (30 Days)
  • CPRX 984.3K
  • COMP 4.8M
  • Earning Date
  • CPRX 11-06-2024
  • COMP 10-30-2024
  • Dividend Yield
  • CPRX N/A
  • COMP N/A
  • EPS Growth
  • CPRX 114.68
  • COMP N/A
  • EPS
  • CPRX 1.18
  • COMP N/A
  • Revenue
  • CPRX $460,482,000.00
  • COMP $5,345,100,000.00
  • Revenue This Year
  • CPRX $21.99
  • COMP $15.25
  • Revenue Next Year
  • CPRX $17.95
  • COMP $14.58
  • P/E Ratio
  • CPRX $17.48
  • COMP N/A
  • Revenue Growth
  • CPRX 32.17
  • COMP 9.18
  • 52 Week Low
  • CPRX $13.00
  • COMP $1.99
  • 52 Week High
  • CPRX $24.27
  • COMP $7.01
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 39.71
  • COMP 51.31
  • Support Level
  • CPRX $21.30
  • COMP $6.59
  • Resistance Level
  • CPRX $24.27
  • COMP $6.98
  • Average True Range (ATR)
  • CPRX 0.79
  • COMP 0.38
  • MACD
  • CPRX -0.18
  • COMP 0.01
  • Stochastic Oscillator
  • CPRX 4.18
  • COMP 57.93

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

Share on Social Networks: